Takayasu's arteritis

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Risk factors

By Mayo Clinic staff

Takayasu's arteritis primarily affects young girls and women in their 20s and 30s. The disorder occurs worldwide, but it's most common in Asian women.

Complications Causes

  • See Also

    • Hand Scheduled
    Section Focus
    Related Links
  • Vasculitis

    • Related Guides
    Children
    Parent
References
  1. Takayasu's arteritis. Vasculitis Foundation. http://staging.vasculitisfoundation.org/education/forms/takayasus-arteritis/ Accessed Jan. 22, 2013.
  2. Imboden JB, et al. Current Rheumatology Diagnosis & Treatment. 2nd ed. New York, N.Y.: The McGraw-Hill Companies; 2007. http://www.accessmedicine.com/resourceTOC.aspx?resourceID=38. Accessed Jan. 22, 2013.
  3. Minagar A, et al. Neurologic presentations of systemic vasculitides. Neurology Clinics. 2010;28:171.
  4. Longo DL, et al. Harrison's Online. 18th ed. New York, N.Y.: The McGraw-Hill Companies; 2012. http://www.accessmedicine.com/resourceTOC.aspx?resourceID=4. Accessed Jan. 22, 2013.
  5. Takayasu's arteritis. American College of Rheumatology. http://www.rheumatology.org/practice/clinical/patients/diseases_and_conditions/takayasusartritis.asp. Accessed Jan. 22, 2013.
  6. Mandal D, et al. Takayasu arteritis in pregnancy: An analysis from eastern India. Archives in Gynecology and Obstetrics. 2012;285:567.
  7. Ohigashi H, et al. Improved prognosis of Takayasu arteritis over the past decade. Circulation Journal. 2012;76:1004.
  8. Schmidt J, et al. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: Experience from a referral center with long-term follow-up. Arthritis Care and Research. 2012;64:1079.
  9. Comarmond C, et al. Anti TNF-alpha in refractory Takayasu's arteritis: Cases series and review of the literature. Autoimmunity Reviews 2012;11:678.
  10. Salvarani C, et al. Tocilizumab:A novel therapy for patients with large-vessel vasculitis. Rheumatology. 2012;51:151.
  11. Shields RC (expert opinion). Mayo Clinic, Rochester, Minn., Feb. 10, 2013.
DS00832 March 13, 2013

© 1998-2013 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

  • Reprints
  • Print

  • Share on:

  • Email

Advertisement


Text Size: smaller largerlarger